T. Yamaji

发表

Neuroimmunophilin ligands improve functional recovery and increase axonal growth after spinal cord hemisection in rats.

J. Voda, T. Yamaji, B. Gold, 2005, Journal of neurotrauma.

FK1706, a novel non-immunosuppressant neurophilin ligand, ameliorates motor dysfunction following spinal cord injury through its neuroregenerative action.

T. Yamaji, N. Matsuoka, S. Mutoh, 2008, European journal of pharmacology.

Pharmacological characterization of standard analgesics on mechanical allodynia in streptozotocin-induced diabetic rats

T. Yamaji, T. Aoki, Hiroko Yamamoto, 2009, Neuropharmacology.

FK1706, a novel non-immunosuppressive immunophilin ligand, modifies the course of painful diabetic neuropathy

T. Yamaji, Hiroko Yamamoto, N. Matsuoka, 2008, Neuropharmacology.

A Simple, Flexible, Nonfluorescent System for the Automated Screening of Neurite Outgrowth

T. Yamaji, N. Matsuoka, R. Price, 2006, Journal of biomolecular screening.

Drug Discovery for PTSD: Characterization of an Animal Model of PTSD and PET Imaging of Brain Glucocorticoid Receptor

T. Yamaji, S. Nishimura, N. Matsuoka, 2006 .

Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.

T. Yamaji, T. Mihara, N. Matsuoka, 2006, European journal of pharmacology.

KP544 amplifies the effects of nerve growth factor on cell differentiation and is neuroprotective

T. Yamaji, L. Beauchamp, N. Matsuoka, 2004 .

A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease.

Katsuya Harada, Kazuhiro Nakato, Takayuki Yamaji, 2012, European journal of pharmacology.

Effects of packaging and heat transfer kinetics on drug-product stability during storage under uncontrolled temperature conditions.

T. Yamaji, K. Takayama, Toru Nakamura, 2013, Journal of pharmaceutical sciences.

Pharmacological characterization of FR194921, a new potent, selective, and orally active antagonist for central adenosine A1 receptors.

A. Iwashita, T. Yamaji, T. Mihara, 2004, Journal of pharmacological sciences.

FK1706, a novel non-immunosuppressive immunophilin: neurotrophic activity and mechanism of action.

T. Yanagihara, T. Yamaji, B. Gold, 2005, European journal of pharmacology.

FK506 potentiates NGF‐induced neurite outgrowth via the Ras/Raf/MAP kinase pathway

T. Yamaji, N. Matsuoka, R. Price, 2003, British journal of pharmacology.

FK1706, a novel non-immunosuppressive immunophilin ligand, modifies gene expression in the dorsal root ganglia during painful diabetic neuropathy

T. Yamaji, Hiroko Yamamoto, N. Matsuoka, 2012, Neurological research.

Glucocorticoid receptor activation is involved in producing abnormal phenotypes of single-prolonged stress rats: A putative post-traumatic stress disorder model

K. Kohda, T. Yamaji, J. Motohashi, 2007, Neuroscience.

Roles of glutamate signaling in preclinical and/or mechanistic models of depression

K. Hashimoto, T. Yamaji, K. Tokita, 2012, Pharmacology Biochemistry and Behavior.

FK962, a novel enhancer of somatostatin release, exerts cognitive-enhancing actions in rats.

T. Yamaji, K. Tokita, N. Matsuoka, 2005, European journal of pharmacology.

Activation of the serotonin 5-HT2C receptor is involved in the enhanced anxiety in rats after single-prolonged stress

T. Yamaji, N. Matsuoka, K. Harada, 2008, Pharmacology Biochemistry and Behavior.

Depressive-like behavior in adrenocorticotropic hormone-treated rats blocked by memantine

Yuko Fujita, K. Hashimoto, T. Yamaji, 2012, Pharmacology Biochemistry and Behavior.